Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Pulmonary Tuberculosis IV

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HIGH INCIDENCE OF SEVERE PARASITEMIA IN FALCIPARUM MALARIA.

Medical journal, Armed Forces India·2017

Same author

HIV AND TUBERCULOSIS CO-INFECTION IN A REFERRAL CHEST HOSPITAL.

Medical journal, Armed Forces India·2017

Same author

ALVEOLAR PROTEINOSIS (A Case Report).

Medical journal, Armed Forces India·2017

Same author

HIV IN TUBERCULOSIS.

Medical journal, Armed Forces India·2017

Same author

A STUDY OF SUPERIOR VENA CAVA OBSTRUCTION SYNDROME.

Medical journal, Armed Forces India·2017

Same author

DRUG RESISTANT TUBERCULOSIS.

Medical journal, Armed Forces India·2017

Search research articles

Related Experiment Video

Updated: Feb 25, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

MULTIDRUG RESISTANT PULMONARY TUBERCULOSIS A CLINICAL PROFILE OF 28 CASES.

D Rosha¹, P K Dandona¹, R Jayaswal²

¹Classified Specialist (Medicine and Chest Diseases), Army Hospital Delhi Cantt 110010.

Medical Journal, Armed Forces India

|August 4, 2017

Summary

This summary is machine-generated.

This study examined 28 multidrug-resistant pulmonary tuberculosis cases treated with second-line drugs. Outcomes included treatment success, failure, and default, highlighting the challenges in managing resistant tuberculosis.

Keywords:

Multidrug resistance Pulmonary tuberculosis

More Related Videos

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Related Experiment Videos

Last Updated: Feb 25, 2026

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis

Published on: August 11, 2008

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates

Published on: September 5, 2017

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Area of Science:

Medicine
Infectious Diseases
Pulmonology

Background:

Multidrug-resistant tuberculosis (MDR-TB) poses a significant global health challenge.
Effective treatment strategies for MDR-TB are crucial for patient outcomes and disease control.

Purpose of the Study:

To describe the clinical profile and treatment outcomes of patients with multidrug-resistant pulmonary tuberculosis.
To evaluate the effectiveness of second-line antitubercular treatment in a cohort of MDR-TB patients.

Main Methods:

Retrospective study of 28 patients with sputum culture-proved multidrug-resistant pulmonary tuberculosis.
All patients received appropriate second-line antitubercular treatment.
Data collected on drug resistance patterns, treatment adherence, and clinical outcomes.

Main Results:

Seven patients (25%) defaulted from treatment.
Two patients (7.1%) experienced second-line drug failure, with one successfully treated with surgery.
Three patients (10.7%) were cured with drug therapy, and 8 (28.5%) converted at 6 months; 16 (57%) were still undergoing treatment.

Conclusions:

Second-line drug treatment for multidrug-resistant pulmonary tuberculosis shows variable outcomes.
Patient adherence and timely intervention, including surgical options, are critical for successful MDR-TB management.
Further research is needed to optimize treatment regimens for resistant TB strains.